Table 4.
Outcomes and follow-up data
| Variable | Result (n=22) |
|---|---|
|
| |
| Days from onset to TEVAR | |
| Acute (≤14 days) | 8 (36.4) |
| Subacute (>14 days, <3 months) | 5 (22.7) |
| Chronic (>3 months) | 9 (40.9) |
| TBAD with aneurysm degeneration | 6 (31.8) |
| Complications | |
| Endoleak | 0 |
| Paraplegia | 0 |
| Stroke | 0 |
| Distal SINE | 0 |
| Acute renal failure | 0 |
| Bow and limb ischemia | 0 |
| RBS collapsed | 3 (13.6) |
| Reintervention for all causes | 0 (0) |
| 30-day mortality | 0 (0) |
| Overall aorta-related death | 1 (4.5) |
Note: Categorical data are presented as number (%).
Abbreviations: RBS, restrictive bare stent; SINE, stent graft-induced new entry; TBAD, type B aortic dissection; TEVAR, thoracic endovascular aortic repair.